Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials (Q21090712)

From Wikidata

Jump to navigation Jump to search

scientific article

Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Language	Label	Description	Also known as
English	Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials	scientific article	Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Statements

scholarly article

0 references

5 references

25 April 2019

17 September 2019

19 September 2019

7 November 2019

13 September 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials (English)

0 references

Alzheimer's disease

6 references

25 April 2019

17 September 2019

19 September 2019

7 November 2019

based on heuristic

inferred from title

13 September 2020

0 references

heterocyclic compound

1 reference

17 September 2019

biomedical investigative technique

1 reference

19 September 2019

1 reference

7 November 2019

1 reference

13 September 2020

systematic review

1 reference

based on heuristic

inferred from title

1

object named as

Guoyan Yang

author given names

Guoyan

author last names

Yang

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Yuyi Wang

2

author given names

Yuyi

author last names

Wang

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jinzhou Tian

3

author given names

Jinzhou

author last names

Tian

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jian-Ping Liu

4

author given names

Jian-Ping

author last names

Liu

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

0 references

publication date

23 September 2013

5 references

25 April 2019

17 September 2019

19 September 2019

7 November 2019

13 September 2020

6 references

25 April 2019

17 September 2019

19 September 2019

7 November 2019

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

13 September 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

e74916

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

copyright license

Creative Commons Attribution 4.0 International

5 references

Europe PubMed Central

25 April 2019

Europe PubMed Central

17 September 2019

Europe PubMed Central

19 September 2019

Europe PubMed Central

7 November 2019

Europe PubMed Central

13 September 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

19 March 2017

Huperzine A for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

19 March 2017

Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

12 September 2017

The discovery of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

12 September 2017

A phase II trial of huperzine A in mild to moderate Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

12 September 2017

Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

12 September 2017

A systematic review of single chinese herbs for Alzheimer's disease treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

12 September 2017

Herbal therapy: a new pathway for the treatment of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

27 September 2017

Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3781107

30 May 2018

Cochrane Database of Systematic Reviews

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0074916

21 January 2018

[Anti-cholinesterase activity of huperzine A]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24086396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24086396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0074916

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

2013PLoSO...874916Y

0 references

release_d65uonubwzhcxlkceacj37phz4

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24086396%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21090712&oldid=1951767597"